tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PCVX Stock Latest News

Vaxcyte Appoints John Furey as New Independent Board Director
Company AnnouncementsVaxcyte Appoints John Furey as New Independent Board Director
22d ago
8K
PCVX
Vaxcyte Appoints John Furey to Board of Directors
PremiumPress Releases
Vaxcyte Appoints John Furey to Board of Directors
23d ago
PCVX
Vaxcyte appoints John Furey to board of directors
PremiumThe Fly
Vaxcyte appoints John Furey to board of directors
23d ago
PCVX
Vaxcyte management to meet virtually with Mizuho
PremiumThe Fly
Vaxcyte management to meet virtually with Mizuho
2M ago
PCVX
Vaxcyte management to meet virtually with Mizuho
PremiumThe Fly
Vaxcyte management to meet virtually with Mizuho
2M ago
PCVX
Vaxcyte files automatic mixed securities shelf
PremiumThe FlyVaxcyte files automatic mixed securities shelf
2M ago
PCVX
Vaxcyte reports Q1 EPS (85c), consensus ($1.17)
PremiumThe Fly
Vaxcyte reports Q1 EPS (85c), consensus ($1.17)
3M ago
PCVX
PCVX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PCVX Upcoming Earnings Report: What to Expect?
3M ago
PCVX
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
PremiumPress Releases
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
4M ago
PCVX
Vaxcyte price target raised to $113 from $69 at Mizuho
PremiumThe Fly
Vaxcyte price target raised to $113 from $69 at Mizuho
4M ago
PCVX
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
PremiumPress Releases
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
5M ago
PCVX
Vaxcyte completes enrollment of Phase 2 study evaluating VAX-24
PremiumThe Fly
Vaxcyte completes enrollment of Phase 2 study evaluating VAX-24
5M ago
PCVX
Vaxcyte price target raised to $95 from $73 at Needham
PremiumThe FlyVaxcyte price target raised to $95 from $73 at Needham
5M ago
PCVX
Vaxcyte price target raised to $98 from $76 at BTIG
PremiumThe Fly
Vaxcyte price target raised to $98 from $76 at BTIG
5M ago
PCVX
Vaxcyte reports Q 4 net loss $180.8M vs $78.1M last year
PremiumThe Fly
Vaxcyte reports Q 4 net loss $180.8M vs $78.1M last year
5M ago
PCVX
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
5M ago
PCVX
PCVX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PCVX Upcoming Earnings Report: What to Expect?
5M ago
PCVX
Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
PremiumPress Releases
Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
5M ago
PCVX
Vaxcyte price target raised to $92 from $80 at BofA
PremiumThe Fly
Vaxcyte price target raised to $92 from $80 at BofA
6M ago
PCVX
Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
PremiumPress ReleasesVaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
6M ago
PCVX
Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
PremiumPress Releases
Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
6M ago
PCVX
Vaxcyte Secures $816.5 Million in Stock and Warrant Sale
PremiumCompany Announcements
Vaxcyte Secures $816.5 Million in Stock and Warrant Sale
6M ago
8K
PCVX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >